Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma

Prognostic and clinical significance of syndecan-1 in colorectal cancer: a meta-analysis

(2015) Hao-tang Wei et al.   BMC GASTROENTEROLOGY

Syndecan-1 Expression Is Associated with Tumor Size and EGFR Expression in Colorectal Carcinoma: A Clinicopathological Study of 230 Cases

(2015) Su Young Kim et al.   International Journal of Medical Sciences

The consensus molecular subtypes of colorectal cancer

(2015) Justin Guinney et al.   NATURE MEDICINE

Serum Syndecan-1 Levels and Its Relationship to Disease Activity in Patients with Crohn’s Disease

(2015) Cem Çekiç et al.   Gastroenterology Research and Practice

Syndecan-1 and Its Expanding List of Contacts

(2015) Mary Ann Stepp et al.   Advances in Wound Care

Carbohydrate-Containing Molecules as Potential Biomarkers in Colon Cancer

(2014) Eun Ji Joo et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Heparan sulfate signaling in cancer

(2014) Erik H. Knelson et al.   TRENDS IN BIOCHEMICAL SCIENCES

CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis

(2013) Hiroshi Katoh et al.   CANCER CELL

Syndecan-1 and Heparanase

(2013) Shaoheng Zhang et al.   INFLAMMATORY BOWEL DISEASES

Maresin 1, a Proresolving Lipid Mediator Derived from Omega-3 Polyunsaturated Fatty Acids, Exerts Protective Actions in Murine Models of Colitis

(2013) R. Marcon et al.   JOURNAL OF IMMUNOLOGY

Syndecan-1, a Cell Surface Proteoglycan, Negatively Regulates Initial Leukocyte Recruitment to the Brain across the Choroid Plexus in Murine Experimental Autoimmune Encephalomyelitis

(2013) X. Zhang et al.   JOURNAL OF IMMUNOLOGY

Low Molecular Weight Heparin Relieves Experimental Colitis in Mice by Downregulating IL-1β and Inhibiting Syndecan-1 Shedding in the Intestinal Mucosa

(2013) Xian-fei Wang et al.   PLoS One

Evaluation of chemical mediators and cellular response during acute and chronic gut inflammatory response induced by dextran sodium sulfate in mice

(2012) Allisson Freire Bento et al.   BIOCHEMICAL PHARMACOLOGY

Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway

(2012) Monika Julia Wolf et al.   CANCER CELL

Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?

(2012) Andrew Jarnicki et al.   Cell Division

The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment

(2011) Ning Li et al.   CANCER CELL

Expression of heparan sulfate proteoglycans in murine models of experimental colitis*

(2011) A. M. Patterson et al.   INFLAMMATORY BOWEL DISEASES

Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice

(2011) Immanuel Lerner et al.   JOURNAL OF CLINICAL INVESTIGATION

Beneficial Effect of Glatiramer Acetate Treatment on Syndecan-1 Expression in Dextran Sodium Sulfate Colitis

(2011) D. Yablecovitch et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Molecular functions of syndecan-1 in disease

(2011) Yvonne Hui-Fang Teng et al.   MATRIX BIOLOGY

Transmembrane Signaling Proteoglycans

(2010) John R. Couchman   Annual Review of Cell and Developmental Biology

Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation

(2010) Maralice Conacci-Sorrell et al.   CELL

Heparanase Plays a Dual Role in Driving Hepatocyte Growth Factor (HGF) Signaling by Enhancing HGF Expression and Activity

(2010) Vishnu C. Ramani et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer

(2010) S Danese et al.   ONCOGENE

Enoxaparin Improves the Course of Dextran Sodium Sulfate-Induced Colitis in Syndecan-1-Deficient Mice

(2009) Martin Floer et al.   AMERICAN JOURNAL OF PATHOLOGY

gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis

(2009) Julia Bollrath et al.   CANCER CELL

IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer

(2009) Sergei Grivennikov et al.   CANCER CELL

The signaling mechanisms of syndecan heparan sulfate proteoglycans

(2009) Kathleen Lambaerts et al.   CURRENT OPINION IN CELL BIOLOGY

Inflammation and oncogenesis: a vicious connection

(2009) Sergei I Grivennikov et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

(2009) Julia Bollrath et al.   EMBO REPORTS

Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis

(2009) Y. Li et al.   GUT

Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity

(2009) B. K. Masouleh et al.   JOURNAL OF IMMUNOLOGY

Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: An immunohistochemical study of clinically annotated tumors

(2008) Yosuke Hashimoto et al.   BMC CANCER

Syndecan-1 Is anin VivoSuppressor of Gram-positive Toxic Shock

(2008) Kazutaka Hayashida et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Heparanase Stimulation of Protease Expression Implicates It as a Master Regulator of the Aggressive Tumor Phenotype in Myeloma

(2008) Anurag Purushothaman et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function

(2008) Lars Bode et al.   JOURNAL OF CLINICAL INVESTIGATION

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE